Craft

Olympus

Stock Price

¥2.7 K

2024-10-29

Market Capitalization

¥3.1 T

2024-10-29

Revenue

¥936.2 B

FY, 2024

Olympus Summary

Company Summary

Overview
Olympus (オリンパス株式会社) is a company that manufactures and sells medical machinery and instruments. It operates through two divisions: endoscopic solutions and therapeutic solutions. The endoscopic sector includes gastrointestinal and surgical endoscopy systems, endoscope reprocessors, digital healthcare, and other solutions. The therapeutic sector provides endotherapy, urology, respiratory devices and systems, rhino-laryngo scopes, etc.
Type
Public
Status
Active
Founded
1919
HQ
Tokyo, JP | view all locations
Website
https://www.olympus-global.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Yasuo Takeuchi

    Yasuo Takeuchi, Director, Representative Executive Officer, Executive Chairperson and ESG Officer

  • Naoki Okada

    Naoki Okada, Managing Director, Korea

    • Marc Radatt

      Marc Radatt, Chief Executive Officer, APAC

    • Samson Chan

      Samson Chan, Managing Director, Hong Kong

      Operating MetricsView all

      Colonoscopies Performed

      50M

      FY, 2023

      Diseases Treated

      100

      FY, 2023

      Participants Served

      13.8K
      31.4%

      FY, 2023

      LocationsView all

      51 locations detected

      • Tokyo, Tokyo HQ

        Japan

        2951 Ishikawa-machi, Hachioji-shi

      • Center Valley, PA

        United States

        3500 Corporate Pkwy

      • Miami, FL

        United States

        5301 Blue Lagoon Drive, Suite 290

      • Westborough, MA

        United States

        800 W Park Dr

      • Victoria, VIC

        Australia

        3 Acacia Place, Notting Hill

      • Vienna, Wien

        Austria

        Shuttleworthstrasse 25

      and 45 others

      Olympus Financials

      Summary Financials

      Revenue (H1, 2025)
      ¥477.0B
      Gross profit (H1, 2025)
      ¥360.9B
      Net income (H1, 2025)
      ¥49.0B
      Cash (H1, 2025)
      ¥245.9B
      EBIT (H1, 2025)
      ¥70.2B
      Enterprise value
      $3.1T

      Footer menu